Alcor Conference - Chris Heward
Sunday, October 7th, 2007[Alcor Conference - Table of Contents]
[Recap]
Chris Heward discussed his work on the “Kronos Longitudinal Aging Study (KLAS)” as a measurement of human aging. KRONOS Science Laboratory is a research institution in Phoenix, AZ, USA.
Heward showed a graph of progress in life expectancy at birth and at 65. Life expectancy at birth has experienced obvious improvement, but not so for life expectancy at age 65. Looking at particular biomarkers of again, we follow a peak around age 20 with a downhill degeneration to death. Once measures of life expectancy can be developed, than potential interventions can be tested against these biomarkers for effectiveness.
Data is collect in a database based on a variety of tests. For most Kronos participants, this includes one or two data collection events. Longitudinal studies require repeat testing over many years.
One of the best known biochemical biomarkers Kronos has found for aging is DHEA-SO4. The lower the level, the older the patient. However, although a line has been drawn on a graph to show this, the individual results actually do not cluster very well. Kronos next compared biomarkers with each other, but found little correlation, suggesting aging is not just one underlying problem, but multiple.
Kronos’ approach to aging is to assess and prevent issues earlier than people are usually treated. They focus on the top killers, like cardiovascular disease. They look for oxidative stress, with the goal of providing high levels of protection and reducing damage.
Their latest findings suggest it is difficult to assess a person’s oxidative stress using only one biomarker. Damage is variable over different testing periods.